Rachel Laskey
Overview
Explore the profile of Rachel Laskey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
489
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Szarek M, Amarenco P, Callahan A, DeMicco D, Fayyad R, Goldstein L, et al.
J Am Coll Cardiol
. 2020 Mar;
75(17):2110-2118.
PMID: 32194196
Background: In the SPARCL (Stroke Prevention by Aggressive Reduction in Cholesterol Levels) trial, atorvastatin was compared with placebo in 4,731 participants with recent stroke or transient ischemic attack and no...
2.
Waters D, Bangalore S, Fayyad R, DeMicco D, Laskey R, Melamed S, et al.
J Clin Lipidol
. 2018 Jan;
12(2):356-366.
PMID: 29310989
Background: Higher visit-to-visit variability in risk factors such as blood pressure and low-density lipoprotein (LDL)-cholesterol are associated with an increase in cardiovascular (CV) events. Objective: The purpose of this study...
3.
Ports W, Fayyad R, DeMicco D, Laskey R, Wolk R
Clin Drug Investig
. 2017 Jun;
37(8):775-785.
PMID: 28573499
Background: Psoriasis is associated with dyslipidemia and metabolic syndrome, and has been linked to an increased cardiovascular risk. The aim of this study was to compare baseline characteristics and effects...
4.
Bangalore S, Fayyad R, Laskey R, DeMicco D, Messerli F, Waters D
N Engl J Med
. 2017 Apr;
376(14):1332-1340.
PMID: 28379800
Background: Body-weight fluctuation is a risk factor for death and coronary events in patients without cardiovascular disease. It is not known whether variability in body weight affects outcomes in patients...
5.
Byun Y, Yang X, Bao W, DeMicco D, Laskey R, Witztum J, et al.
J Am Coll Cardiol
. 2017 Jan;
69(2):147-158.
PMID: 28081824
Background: Biomarkers to predict recurrent stroke and targets of therapy to prevent stroke are lacking. Objectives: This study evaluated whether patients with prior cerebrovascular events and elevated levels of oxidized...
6.
Bangalore S, Fayyad R, Messerli F, Laskey R, DeMicco D, Kastelein J, et al.
Am J Cardiol
. 2016 Dec;
119(3):379-387.
PMID: 27939230
In patients with previous myocardial infarction (MI), aggressive hypertension control and low-density lipoprotein cholesterol (LDL-C) reduction are important secondary prevention measures. However, residual risk remains despite aggressive treatment. Whether variability...
7.
Chan J, Kong A, Bao W, Fayyad R, Laskey R
Cardiovasc Ther
. 2016 Aug;
34(6):431-440.
PMID: 27520479
Introduction: Data on statin safety in Asian patients are limited compared with evidence from Western populations. Aim: This study assessed atorvastatin safety among Asian patients enrolled in 58 randomized clinical...
8.
Arsenault B, Kohli P, Lambert G, DeMicco D, Laskey R, Messig M, et al.
Am J Cardiol
. 2016 Jun;
118(4):494-8.
PMID: 27328952
Whether biomarkers associated with cardiovascular disease risk also predict incident diabetes mellitus (DM) is unknown. Our objective was to determine if a panel of 18 biomarkers previously associated with risk...
9.
Bangalore S, Fayyad R, Kastelein J, Laskey R, Amarenco P, DeMicco D, et al.
Am J Med
. 2015 Nov;
129(4):384-91.
PMID: 26551986
Background: The 2013 American College of Cardiology (ACC)/American Heart Association (AHA) guideline on the treatment of blood cholesterol recommends moderate- to high-intensity statins for patients with atherosclerotic cardiovascular disease but...
10.
Byun Y, Lee J, Arsenault B, Yang X, Bao W, DeMicco D, et al.
J Am Coll Cardiol
. 2015 Apr;
65(13):1286-1295.
PMID: 25835440
Background: Oxidized phospholipids on apolipoprotein B-100 (OxPL-apoB) is a biomarker of increased risk for major adverse cardiovascular events (MACE) in community cohorts, but its role in patients with stable coronary...